Trial Profile
Clinical Trials Insight: 700007865
Status:
Completed
Phase of Trial:
Phase I/II
Latest Information Update: 01 Oct 2007
Price :
$35
*
At a glance
- Drugs Elvitegravir (Primary) ; Ritonavir (Primary)
- Indications HIV-1 infections
- Focus Adverse reactions; Therapeutic Use
- 14 Nov 2005 New trial record.